151 related articles for article (PubMed ID: 26319900)
1. Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.
Altman MK; Alshamrani AA; Jia W; Nguyen HT; Fambrough JM; Tran SK; Patel MB; Hoseinzadeh P; Beedle AM; Murph MM
Cancer Lett; 2015 Dec; 369(1):175-83. PubMed ID: 26319900
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.
Yu J; Henske EP
Cancer Res; 2006 Oct; 66(19):9461-6. PubMed ID: 17018601
[TBL] [Abstract][Full Text] [Related]
3. Rheb, an activator of target of rapamycin, in the blackback land crab, Gecarcinus lateralis: cloning and effects of molting and unweighting on expression in skeletal muscle.
MacLea KS; Abuhagr AM; Pitts NL; Covi JA; Bader BD; Chang ES; Mykles DL
J Exp Biol; 2012 Feb; 215(Pt 4):590-604. PubMed ID: 22279066
[TBL] [Abstract][Full Text] [Related]
4. Rheb binds and regulates the mTOR kinase.
Long X; Lin Y; Ortiz-Vega S; Yonezawa K; Avruch J
Curr Biol; 2005 Apr; 15(8):702-13. PubMed ID: 15854902
[TBL] [Abstract][Full Text] [Related]
5. Rheb and mTOR regulate neuronal polarity through Rap1B.
Li YH; Werner H; Püschel AW
J Biol Chem; 2008 Nov; 283(48):33784-92. PubMed ID: 18842593
[TBL] [Abstract][Full Text] [Related]
6. The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity.
Basso AD; Mirza A; Liu G; Long BJ; Bishop WR; Kirschmeier P
J Biol Chem; 2005 Sep; 280(35):31101-8. PubMed ID: 16006564
[TBL] [Abstract][Full Text] [Related]
7. Rheb activation of mTOR and S6K1 signaling.
Hanrahan J; Blenis J
Methods Enzymol; 2006; 407():542-55. PubMed ID: 16757352
[TBL] [Abstract][Full Text] [Related]
8. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin.
Kimball SR; Jefferson LS
Curr Opin Clin Nutr Metab Care; 2004 Jan; 7(1):39-44. PubMed ID: 15090902
[TBL] [Abstract][Full Text] [Related]
10. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
Hooks SB; Callihan P; Altman MK; Hurst JH; Ali MW; Murph MM
Mol Cancer; 2010 Nov; 9():289. PubMed ID: 21044322
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided mutation of the conserved G3-box glycine in Rheb generates a constitutively activated regulator of mammalian target of rapamycin (mTOR).
Mazhab-Jafari MT; Marshall CB; Ho J; Ishiyama N; Stambolic V; Ikura M
J Biol Chem; 2014 May; 289(18):12195-201. PubMed ID: 24648513
[TBL] [Abstract][Full Text] [Related]
12. Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.
Hanker AB; Mitin N; Wilder RS; Henske EP; Tamanoi F; Cox AD; Der CJ
Oncogene; 2010 Jan; 29(3):380-91. PubMed ID: 19838215
[TBL] [Abstract][Full Text] [Related]
13. RGS10 Regulates the Expression of Cyclooxygenase-2 and Tumor Necrosis Factor Alpha through a G Protein-Independent Mechanism.
Alqinyah M; Almutairi F; Wendimu MY; Hooks SB
Mol Pharmacol; 2018 Oct; 94(4):1103-1113. PubMed ID: 30049816
[TBL] [Abstract][Full Text] [Related]
14. PRL-3 activates mTORC1 in Cancer Progression.
Ye Z; Al-Aidaroos AQ; Park JE; Yuen HF; Zhang SD; Gupta A; Lin Y; Shen HM; Zeng Q
Sci Rep; 2015 Nov; 5():17046. PubMed ID: 26597054
[TBL] [Abstract][Full Text] [Related]
15. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
16. Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase.
Yan L; Findlay GM; Jones R; Procter J; Cao Y; Lamb RF
J Biol Chem; 2006 Jul; 281(29):19793-7. PubMed ID: 16728407
[TBL] [Abstract][Full Text] [Related]
17. Identification of dominant negative mutants of Rheb GTPase and their use to implicate the involvement of human Rheb in the activation of p70S6K.
Tabancay AP; Gau CL; Machado IM; Uhlmann EJ; Gutmann DH; Guo L; Tamanoi F
J Biol Chem; 2003 Oct; 278(41):39921-30. PubMed ID: 12869548
[TBL] [Abstract][Full Text] [Related]
18. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.
Long X; Ortiz-Vega S; Lin Y; Avruch J
J Biol Chem; 2005 Jun; 280(25):23433-6. PubMed ID: 15878852
[TBL] [Abstract][Full Text] [Related]
19. Influence of miR-155 on Cell Apoptosis in Rats with Ischemic Stroke: Role of the Ras Homolog Enriched in Brain (Rheb)/mTOR Pathway.
Xing G; Luo Z; Zhong C; Pan X; Xu X
Med Sci Monit; 2016 Dec; 22():5141-5153. PubMed ID: 28025572
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the small GTPase Rheb by amino acids.
Roccio M; Bos JL; Zwartkruis FJ
Oncogene; 2006 Feb; 25(5):657-64. PubMed ID: 16170341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
